Standigm ranked third in the AstraZeneca-Sanger drug Combination Prediction Dream Challenge

Updated:

Standigm had participated in the AstraZeneca-Sanger Drug Combination Prediction Dream Challenge hosted by one of the leading pharmaceutical companies, AstraZeneca. Standigm team ranked third among 71 international teams. Standigm will apply the methods to precision medicine, patient stratification, and therapeutic/diagnostic design.

Read result

Read more in Korean press

etnews

Categories: News